공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

바이오인포매틱스 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Bioinformatics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 390860
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


바이오인포매틱스 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Bioinformatics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 바이오인포매틱스(Bioinformatics) 시장에 대해 조사했으며, 시장 기회와 동향, 성장 촉진요인 및 저해요인, 제품과 서비스·용도·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사 가정
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 핵산 및 단백질 시퀀싱 수요 증가
    • 정부 및 민간 조직으로부터의 대처 증가
    • 프로테오믹스 및 게노믹스의 성장 가속
    • 분자생물학 및 Drug Discovery에 관한 연구 증가
  • 시장 성장 저해요인
    • 명확하게 정의된 표준 및 데이터 통합을 위한 일반적인 데이터 형식의 결여
    • 데이터의 복잡성 우려 및 사용자 친화적 툴의 결여
  • Porter's Five Forces 분석
    • 신규 참여업체의 위협
    • 바이어/소비자의 협상력
    • 공급업체의 협상력
    • 대체 제품의 위협
    • 업계내의 경쟁

제5장 시장 세분화

  • 제품 및 서비스별
    • 지식 관리 툴
    • 바이오인포매틱스 플랫폼
    • 바이오인포매틱스 서비스
  • 용도별
    • 미생물 게놈
    • 유전자 공학
    • 의약품 개발
    • 맞춤형 의료
    • 오믹스
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • Illumina Inc.
    • Life Technologies(Thermo Fischer Scientific)
    • Qiagen NV
    • Agilent Technologies
    • PerkinElmer
    • ABM
    • Accelrys Inc.
    • Geneva Bioinformatics SA
    • Ontoforce
    • Data4Cure
    • Life Map Sciences(Biotime)

제7장 시장 기회 및 향후 동향

KSM 19.12.16

The bioinformatics market is expected to register a CAGR of nearly 10.9% during the forecast period, with a revenue of approximately USD 9,665 million in 2020, and it is expected to reach 19,125 million by 2026.

During viral pandemics, sequencing and analyzing the data can be a valuable tool for the characterization and detection of viruses in the environment, animals, and human beings. Information related to transmission chains is critical for public health control and containment measures, while knowledge of virus variability can guide the development of vaccines and cheaper diagnostic methods.

For instance, in March 2020, the UK government has launched a new alliance called COVID-19 Genomics UK Consortium (COG-UK) to sequence the genomes of SARS-CoV-2 with whole-genome sequencing (WGS), the virus responsible for the current COVID-19 pandemic with an investment of EUR 20 million. The COVID-19 Genomics UK Consortium (COG-UK) is comprised of the NHS, Public Health Agencies, the Wellcome Sanger Institute, and several academic institutions. Thus, has likely to boost the market for bioinformatics over the forecast period.

The growth factors for the global bioinformatics market include the rising demand for nucleic acid and protein sequencing, rising initiatives from private and government organizations, accelerating growth of proteomics and genomics, and rising research on molecular biology and drug discovery. Owing to the above factors, the global bioinformatics market is expected to experience a rapid growth during the forecast period.

Bioinformatics is gaining importance, as a huge amounts of data created through techniques, like protein and nucleic acid sequencing, require data interpretation and management for medical purposes and future researches. Thus,rising demand is expected to drive the bioinformatics market during the forecast period.

Additionally, the introduction of technologically advanced bioinformatics software such as BALL, Bioclipse, RasMol, AUTODOCK and rising market usage of these tools for effective and accurate analysis of biomarkers discovery programs that assist in toxicity detection during the initial stage of the drug development process are expected to boost the industry growth over the upcoming years.

Furthermore, the demand for computational epigenetics, meta-analysis of microarray data, differentially expressed genes, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market. However, the lack of well-defined standards and common data formats for integration of data and data complexity concerns and lack of user-friendly tools is likely to hamper the market growth over forecast period.

Key Market Trends

Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period And Expected To Follow The Same Trend Over Forecast Period

Amid the current pandemic, personalized medicine is advancing at a breakneck speed. The Healthcare industry is focused on conducting personalized medicine and genomics research to better understand COVID-19 susceptibility, measure its impact, and discover potential therapies.

Personalized medicine has increased collaborative efforts between medical institutions, governments and researchers to swiftly develop effective treatments. For instance, in 2020, Summit Biolabs, Inc. and the Colorado Center for Personalized Medicine (CCPM) entered into a broad strategic partnership for conducting research, development, and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

Developments in systems biology and pharmacogenomics have helped personalized medicine to transit from disease-centered and reductionism-based medical practice to system-based, integrative, and human-centered care.

Personalized medicine generates a strong impetus for scaling up the companion diagnostics tests to form personalized medicine for non-oncology cases. Rising prevalence of cancer, which boosts demand for personalized cancer therapeutics and diagnostics is also one of the key factors responsible for the growth of the market. As per data GLOBOCAN 2020, the global burden of cancer has increased to 19.3 million cases in 2020. Growing cancer-related spending is also amongst the drivers for segmental growth.

Europe Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

The outbreak of COVID-19 had an impact on the European bioinformatics market because healthcare services were significantly reduced due to social distancing measures taken by several governments across the globe. Government organizations in various countries, research institutes, and many biotech and pharmaceutical firms are focusing their resources on novel technologies for faster and accurate diagnosis of COVID-19. There is also immense research and work going on that are aimed at developing the vaccines, these R&D workflows utilize sequencing technologies extensively.

In March 2020, the UK government has launched a new alliance called COVID-19 Genomics UK Consortium (COG-UK) to sequence the genomes of SARS-CoV-2 with whole-genome sequencing (WGS), the virus responsible for the current COVID-19 pandemic with an investment of EUR 20 million. The COVID-19 Genomics UK Consortium (COG-UK) is comprised of the NHS, Public Health Agencies, the Wellcome Sanger Institute, and several academic institutions. This has positive impact on the regional maret growth.

A large number of healthcare investments in the European region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including United Kingdom, France and Italy are expected to propel the bioinformatics market in this region mainly.

Several companies are partnering and acquiring to strengthen their position in Bioinformatics market. For example, in 2019, Labfolder GmbH and cubuslab GmbH merged to develop platform for the integration of laboratory equipment and laboratory software control. These mergers are promoting the market growth. In addition, in 2019, TrialScope launched a clinical trials website for EMD Serono. Owing to these factors, the Europe bioinformatics market is expected to experience a boost during the forecast period

Competitive Landscape

Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing
    • 4.2.2 Increasing Initiatives from Governments and Private Organizations
    • 4.2.3 Accelerating Growth of Proteomics and Genomics
    • 4.2.4 Increasing Research on Molecular Biology and Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data
    • 4.3.2 Data Complexity Concerns and Lack of User-friendly Tools
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product and Services
    • 5.1.1 Knowledge Management Tools
    • 5.1.2 Bioinformatics Platform
      • 5.1.2.1 Sequence Analysis Platform
      • 5.1.2.2 Sequence Alignment Platform
      • 5.1.2.3 Sequence Manipulation Platform
      • 5.1.2.4 Structural and Functional Analysis Platform
      • 5.1.2.5 Other Bioinformatics Platforms
    • 5.1.3 Bioinformatics Services
      • 5.1.3.1 Sequencing Services
      • 5.1.3.2 Database and Management Services
      • 5.1.3.3 Data Analysis
      • 5.1.3.4 Other Bioinformatics Services
  • 5.2 By Application
    • 5.2.1 Microbial Genome
    • 5.2.2 Gene Engineering
    • 5.2.3 Drug Development
    • 5.2.4 Omics
    • 5.2.5 Personalized Medicine
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3rd Millennium Inc.
    • 6.1.2 ABM
    • 6.1.3 Affymetrix
    • 6.1.4 Agilent Technologies
    • 6.1.5 BioWisdom Ltd
    • 6.1.6 Celera Corporation
    • 6.1.7 Dassault Systemes
    • 6.1.8 Data4Cure
    • 6.1.9 Geneva Bioinformatics SA
    • 6.1.10 Illumina Inc.
    • 6.1.11 Lineage Cell Therapeutics (BioTime Inc.)
    • 6.1.12 Ontoforce
    • 6.1.13 PerkinElmer
    • 6.1.14 Qiagen NV
    • 6.1.15 Rosetta Biosoftware
    • 6.1.16 Thermo Fischer Scientific (Life Technologies)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q